共 58 条
- [1] Butler CF(2013)Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias J Biol Chem 288 25387-25399
- [2] Peet C(2014)Human P450-like oxidation of diverse proton pump inhibitor drug by ‘gatekeeper’ mutants of flavocytochrome P450 BM3 Biochem J 460 247-259
- [3] Mason AE(2005)Enantiomer/enantiomer interactions between the S- and R-isomers of omeprazole in human cytochrome P450 enzymes: major role of CYP2C19 and CYP3A4 J Pharmacol Exp Ther 315 777-787
- [4] Voice MW(2014)Simultaneous determination of omeprazole and their main metabolites in human urine samples by capillary electrophoresis using electrospray ionization-mass spectrometry detection J Pharm Biomed Anal 92 211-219
- [5] Leys D(2013)Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy Pharmacol Rev 65 578-640
- [6] Munro AW(2006)A simple and sensitive bioanalytical assay for simultaneous determination of omeprazole and its three major metabolites in human blood plasma using RP-HPLC after a simple liquid–liquid extraction procedure J Chromatogr B 844 314-321
- [7] Butler CF(2014)Regioselective hydroxylation of omeprazole enantiomers by bacterial CYP102A1 mutants Drug Metab Dispos 42 1493-1497
- [8] Peet C(2009)The pharmacology of esomeprazole and its role in gastric acid related diseases Expert Opin Drug Metab Toxicol 5 1113-1124
- [9] McLean KJ(2006)Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3 Biochem Biophys Res Commun 346 810-818
- [10] Baynham MT(2014)Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update Drug Saf 10 187-194